等待开盘 08-28 09:30:00 美东时间
+0.010
+0.65%
Genasys Inc. (NASDAQ:GNSS), the global leader in Protective Communications®, today announced approximately $1.4 million in LRAD orders from Asia-Pacific (APAC) and European countries. The Long Range Acoustic Devices® will be deployed for Navy, Coast Guard, Police, and Security applications.
08-18 21:06
On Thursday, Genasys (NASDAQ:GNSS) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation...
08-14 05:29
Genasys (NASDAQ:GNSS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.01 by 1100 percent. This is a 28.57 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $7.295 million which mi...
08-14 04:07
Genasys (GNSS) said on Wednesday that it received a new $2.4M critical infrastructure protection order for one of the nation’s largest utility companies. The 950XTs will be fully integrated with the...
08-05 21:23
Genasys Reports Preliminary Q3 Sales Of $7M-$7.5M And Adj. EBITDA Loss Of $3M-$3.3M
07-31 04:22
Genasys has received more than $13.0 million in mobile mass notification orders from the Army, which has remained a consistent partner across multiple programs. "The Acoustics 360XT mobile systems will be deployed overseas to Forward Operating Sites to provide area-wide mass notification, alerts, a...
07-08 21:06
Genasys ( ($GNSS) ) has provided an update. On June 9, 2026, Genasys Inc. enter...
06-13 04:56
Partnership to Provide Two-Way Integration Between Intterra's Aware Platform and Genasys Protect®Genasys Inc. (NASDAQ:GNSS), the global leader in Protective Communications™, today announced a strategic
06-03 21:06
Ascendiant analyst Edward Woo maintained a Buy rating on Genasys on May 31 and ...
06-03 20:40
今日重点评级关注:Ascendiant Capital:维持Genasys"买入"评级,目标价从5.5美元升至6美元;Citizens:维持Abivax"跑赢大市"评级,目标价从131美元升至187美元
06-03 11:17